DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

Stock Information for DiaMedica Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement
DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline
DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference - ESOC 2025
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.